Scotts Miracle-Gro (SMG) EBITDA (2009 - 2026)

Scotts Miracle-Gro has disclosed EBITDA across 18 years of filings, most recently posting $169.6 million for Q2 2026.

• In Q2 2026, EBITDA fell 23.53% year-over-year to $169.6 million; the TTM figure through Jun 2026 stood at $382.5 million (up 23.55% YoY), while the FY2025 annual figure was $358.6 million, up 71.74% from the prior year.
• EBITDA came in at $169.6 million for Q2 2026 at Scotts Miracle-Gro, down from $401.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $401.8 million in Q1 2026 to a low of -$562.5 million in Q3 2022.
• Average EBITDA over 5 years is $26.8 million, with a median of -$21.8 million recorded in 2025.
• Year-over-year, EBITDA slumped 501.88% in 2022 and soared 158.86% in 2024.
• Over 5 years, EBITDA stood at -$41.8 million in 2022, then slipped by 13.16% to -$47.3 million in 2023, then increased by 3.17% to -$45.8 million in 2024, then soared by 52.4% to -$21.8 million in 2025, then soared by 877.98% to $169.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $169.6 million in Q2 2026, $401.8 million in Q1 2026, and -$21.8 million in Q4 2025.